News

Eva König wins Heribert-Konzett-Prize!

A great success! Dr. Eva König, principal investigator at St. Anna CCRI, is honored with the Heribert-Konzett-Prize of the Austrian Pharmacological Society (APHAR) for her scientific work on the interaction between immune and cancer cells. The prize is awarded to recognize the achievements of young scientists already conducting independent research in the field of experimental and clinical pharmacology and to encourage their further development.

Evolution 2.0: What makes cancer more malignant

Evolution 2.0: What makes cancer more malignant (Vienna, 23.09.2022) Congratulations! A paper has just been published in the top journal Nature Genetics, with the participation of Dr. Sabine Taschner-Mandl and Dr. Marie Bernkopf from St. Anna CCRI. The authors of this outstanding paper show that random inheritance patterns of cancer genes outside the chromosome, i.e. the scaffold …

Evolution 2.0: What makes cancer more malignant Read More »

St. Anna CCRI epigenetics researcher Peter Peneder wins ÖGMBT-award!

St. Anna CCRI epigenetics researcher Peter Peneder wins ÖGMBT-award! (Vienna, 20.09.2022) Well done! First place at the Life Science Research Awards Austria 2022 in the category Excellence and Societal Impact – Peter Peneder from Dr. Eleni Tomazou´s tumor epigenetics research group at St. Anna CCRI convinced the jury of the Austrian Society for Molecular Biosciences and …

St. Anna CCRI epigenetics researcher Peter Peneder wins ÖGMBT-award! Read More »

Nerve healing: neighboring cells become police force – and could make tumors benign

Nerve healing: neighboring cells become police force – and could make tumors benign (Vienna, 15.09.2022) Scientists from St. Anna Children´s Cancer Research Institute (St. Anna CCRI) discovered a completely new function of the cells that surround nerve fibers: so-called Schwann cells not only attract immune cells to initiate nerve healing, but also behave like a “police force” …

Nerve healing: neighboring cells become police force – and could make tumors benign Read More »

Two St. Anna CCRI projects selected for FWF’s 1000 ideas program

This year’s 1000 ideas program of FWF promotes another two of St. Anna CCRI’s “completely new, daring or particularly original research ideas that lie outside the current scientific understanding”. Florian Halbritter’s new approach aims to integrate machine learning directly into the experimental design and execution of manufacturing specific cell types from stem cells – with the ultimate goal to reprogram even cancer cells. Artem Kalinichenko, who was also awarded a 1000 ideas grant, is targeting abnormal tumor metabolism by identifying cancer-derived metabolites, drugs and drug metabolites that trigger an immune reaction, which could later be exploited for immunotherapy.

Davide Seruggia earns FWF Stand-Alone funding

To find vulnerabilities of cancers that are driven by MYC, a protein known for its potential to induce tumor growth, is the goal of a new project funded by the Austrian Science Fund FWF. Davide Seruggia from St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and colleagues aim to deactivate this key cancer regulator by targeting components of SAGA, a protein complex tightly linked to MYC. Since pediatric leukemia and neuroblastoma, two of the most common childhood cancers are known to be driven by MYC, establishing new strategies to interrupt its activity in cancer cells is of utmost importance.

St. Anna CCRI goes EHA 2022

St. Anna CCRI goes EHA 2022 (Vienna, 18.6.2022) We have been very excited to attend Europe’s largest conference on hematology here in Vienna: The European Hematology Association (EHA) Hybrid Congress took place from June 9-17 2022 and provided over 1,400 posters, 180 scientific sessions and more than 2,200 selected abstracts. On site, we asked our …

St. Anna CCRI goes EHA 2022 Read More »